A study highlighted a biomarker interaction that may predict breast cancer spread and treatment benefit, focusing on why patients with similar profiles can experience very different outcomes. Researchers reported that the relationship between two genes explained aspects of distant-disease risk beyond standard clinical characterization. The finding points to a path toward more personalized therapy selection, but it will require external validation and prospective testing to confirm that the gene-gene interaction holds up across molecular subtypes and treatment lines.